RNF26 is an E3 ubiquitin ligase that serves as a critical regulator of cellular organization and signaling pathways. The protein functions as a global architect of the endosomal system by localizing to the endoplasmic reticulum membrane and mediating ubiquitination of SQSTM1/p62, which creates a molecular platform that retains vesicles in the perinuclear region and coordinates endosomal trafficking 1. RNF26 contains both leucine zipper and RING finger domains, with the RING domain belonging to a novel C3HC5 subfamily 2. Beyond endosomal organization, RNF26 plays significant roles in cancer progression through multiple mechanisms. It promotes cell cycle progression by degrading p57/CDKN1C in bladder cancer 3 and enhances pancreatic cancer proliferation by targeting RBM38 for degradation 4. In clear cell renal cell carcinoma (ccRCC), RNF26 regulates multiple pathways: it degrades CBX7 to activate TNF signaling and reduce sensitivity to tyrosine kinase inhibitors 5, and functions as an E3 ligase for TSC1, thereby activating mTOR signaling and promoting tumor progression 6. RNF26 expression is upregulated in various cancers including gastric, pancreatic, bladder, and renal cancers, correlating with poor prognosis and representing a potential therapeutic target 243.